(Co)-first Authored Publications

  1. Sugita, M., Yamazaki, T., Alhomoud, M. et al. Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell Death Dis, 2023. 14(5): p. 305.
  2. Yamazaki, T. and L. Galluzzi. BAX and BAK dynamics control mitochondrial DNA release during apoptosis. Cell Death Differ, 2022. 29(6): p. 1296-1298.
  3. Yamazaki, T., Wennerberg, E., Hensler, M. et al. LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology, 2021. 10(1): p. e1962592. 
  4. Yamazaki, T., Bravo-San Pedro, J.M., Galluzzi, L. et al. Autophagy in the cancer-immunity dialogue. Adv Drug Deliv Rev, 2021. 169: p. e40-50.
  5. Yamazaki, T., Kirchmair, A., Sato, A. et al. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nat Immunol, 2020. 21(10): p. 1160-1171.
  6. Yamazaki, T., and L. Galluzzi. Mitochondrial control of innate immune signaling by irradiated cancer cells. Oncoimmunology, 2020. 9(1): p. e1797292. 
  7. Yamazaki, T., Buqué. A., Ames, T.D. and L. Galluzzi. PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology, 2020. 9(1): p. e1721810.
  8. Yamazaki, T., Buqué, A., Rybstein, M. et al. Methods to Detect Immunogenic Cell Death In Vivo. Methods Mol Biol, 2020.  2055: p. 433-452.
  9. Yamazaki, T., Vanpouille-Box, C., Demaria, S. and L. Galluzzi. Immunogenic cell death driven by radiation-impact on the tumor microenvironment. Cancer Treat Res, 2020. 180: p. 281-296.
  10. Yamazaki, T. and L. Galluzzi. TREX cuts down on cancer immunogenicity. Trends Cell Biol, 2017. 27(8): p. e543-545.
  11. Yamazaki, T. and L. Galluzzi. Blinatumomab bridges the gap between leukemia and immunity. Oncoimmunology, 2017. 6(11): p. e1358335. 

(Co)-senior Authored Publications 

  1. Marchi, S., Guilbaud, E., Tait, S.W.G. et al. Mitochondrial control of inflammation. Nat Rev Immunol, 2023. 23(2) p. 159-173.
  2. Álvarez-Abril, B., Bloy, N., Galassi, C. et al. Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods Cell Biol, 2022. 172: p. 17-36.
  3. Galassi, C., Ruan, Y., Sato, A. et al. RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Methods Cell Biol, 2022. 172: p. 145-161. 

Abstracts selected for Oral Presentation (First/co-first and last/co-last only)

  1. Yamazaki, T., Sugita, M., Martinet, J. et al. Boosting CAR T cell expansion and therapeutic activity with low-dose radiation therapy. 62th Annual ASTRO Meeting (Virtual, October 2020).

Abstracts selected for Poster Presentation (First/co-first and last/co-last only)

  1. Yamazaki, T., Wennerberg, E., Hensler, M. et al. Immunotherapeutic and antimetastatic activity of LTX-315 in preclinical models of ICI-resistant breast cancer. 36th Annual SITC Meeting (Washington, D.C., US, November 2021). 
  2. Yamazaki, T., Rybstein, M., Buqué, A. et al. Mitochondrial DNA drives abscopal responses to radiation driven that are inhibited by autophagy. 5thCRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (Paris, France, October 2019).
  3. Yamazaki, T., Rybstein, M., Buqué, A. et al. Mitochondrial DNA drives abscopal responses to radiation driven that are inhibited by autophagy. 4th International Conference on Radiotherapy Immunotherapy Combinations (New York, NY, US, September 2019).
  4. Yamazaki, T., Rybstein, M., Buqué, A. et al. Enhancing abscopal responses by manipulating autophagy. 33rd Annual SITC Meeting (Washington, D.C., US, November 2018).
  5. Yamazaki, T., Ames, T. and L. Galluzzi. Potent induction of immunogenic cell death by PT-112. 4thCRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (New York, NY, US, October 2018).

My Bibliography Link

https://www.ncbi.nlm.nih.gov/myncbi/takahiro.yamazaki.2/bibliography/public/